실험용 유리 기구 및 플라스틱 기구 시장 : 제품 유형, 소재, 최종 사용자, 유통 채널별 - 세계 시장 예측(2026-2032년)

The Laboratory Glassware & Plasticware Market is projected to grow by USD 10.57 billion at a CAGR of 5.94% by 2032.

Laboratory Glassware & Plasticware Market Introduction

The laboratory glassware and plasticware market underpins pharmaceutical R&D, biotechnology, diagnostics, academic research, food testing, environmental monitoring, and industrial quality control. Demand is anchored by recurring consumption of pipette tips, tubes, plates, bottles, flasks, beakers, cylinders, petri dishes, and specialized vessels used in regulated laboratory workflows.

Growth is supported by expanding life sciences research, clinical testing capacity, biologics manufacturing, and public investment in science infrastructure. Buyers increasingly prioritize certified materials, lot traceability, sterility assurance, chemical resistance, low extractables and leachables, ISO-aligned quality systems, and supply continuity across global laboratory operations.

Transformative Shifts in the Laboratory Supplies Landscape

The laboratory supplies landscape is shifting from commodity purchasing to application-specific sourcing. Laboratories are adopting automation-compatible consumables, barcoded containers, low-retention surfaces, pre-sterilized packs, and single-use formats that reduce cross-contamination risk and improve throughput in molecular biology, cell culture, analytical chemistry, and diagnostic testing.

At the same time, sustainability and resilience are reshaping specifications. Borosilicate glass remains essential for thermal and chemical durability, while high-performance plastics such as polypropylene, polystyrene, polycarbonate, polyethylene, and cyclic olefin polymers are selected for workflow efficiency and optical clarity. Recyclability, reusable glass programs, packaging reduction, and regionalized supply chains are becoming competitive differentiators.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is accelerating demand for standardized, machine-readable, and automation-ready labware. AI-enabled drug discovery, high-throughput screening, omics research, digital pathology, and automated sample management require consistent plate geometry, validated consumable dimensions, clean labeling, and reliable material performance to maintain data integrity.

AI also improves manufacturing and distribution. Predictive demand planning, vision-based quality inspection, digital twins for molding and forming processes, defect detection, and automated inventory replenishment reduce stockouts and scrap. For suppliers, AI creates value when paired with validated quality systems, regulatory documentation, interoperable product data, and secure digital procurement workflows.

Key Regional Insights

Asia-Pacific is a major growth engine as China, India, Japan, South Korea, Australia, and ASEAN economies expand pharmaceutical manufacturing, diagnostics, vaccine production, contract research, and academic research capacity. Local production of plastic consumables is increasing across the region, while premium borosilicate glassware demand remains tied to regulated analytical, chemical, and life science laboratories requiring thermal stability and chemical resistance.

North America benefits from strong biomedical funding, FDA-regulated manufacturing, advanced diagnostics, genomics, and a dense network of contract research and testing organizations. Europe is shaped by EU quality, chemical safety, waste reduction, and sustainability requirements, reinforcing demand for traceable, compliant, and recyclable laboratory products. Latin America, led by Brazil and Mexico, is expanding clinical, agricultural, pharmaceutical, and food testing infrastructure, while the Middle East is investing in healthcare modernization, public health laboratories, genomics, water testing, and food safety. Africa is strengthening laboratory capacity through disease surveillance, education, environmental monitoring, and donor-supported public health programs.

Key Economic and Strategic Group Insights

ASEAN is gaining relevance through expanding medical technology manufacturing, hospital networks, pharmaceutical activity, and university research, creating opportunities for cost-effective sterile plastics and durable general-purpose glassware. The GCC is investing in healthcare modernization, genomics, food safety, environmental testing, and national laboratory infrastructure, supporting demand for certified laboratory consumables, temperature-resilient logistics, and reliable import channels.

The European Union emphasizes compliance, sustainability, harmonized quality expectations, chemical safety, and circular economy principles, favoring traceable and recyclable product portfolios. BRICS markets combine large patient populations, pharmaceutical manufacturing, clinical diagnostics, and public research expansion, increasing demand for both routine consumables and higher-specification labware. G7 countries lead in advanced R&D, automation adoption, biologics development, and regulated testing, while NATO members prioritize biosecurity, defense health readiness, emergency response laboratories, and resilient laboratory supply chains.

Key Country Insights

The United States remains a leading demand center due to NIH-supported research, biopharmaceutical production, clinical diagnostics, genomics, and contract laboratory services. Canada benefits from public research networks, hospital laboratories, and biomanufacturing investment, while Mexico is supported by nearshoring, medical manufacturing, pharmaceutical activity, and quality testing. Brazil anchors Latin American demand through public health, agriculture, food safety, environmental testing, and pharmaceutical laboratories.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine strong research institutions, diagnostics, analytical testing, and regulated manufacturing, while Russia maintains demand across healthcare, chemicals, industrial laboratories, and education. China and India are expanding large-scale pharmaceutical manufacturing, clinical testing, vaccine production, and contract research capacity. Japan and South Korea emphasize precision manufacturing, advanced biotechnology, diagnostics, and automation-ready consumables, while Australia supports demand through clinical laboratories, environmental monitoring, mining-related testing, public health, and academic research.

Actionable Recommendations for Industry Leaders

Industry leaders should align product development with validated applications rather than broad commodity catalogs. Priority areas include automation-compatible formats, low-binding and low-leachable materials, sterile and DNase/RNase-free consumables, reusable borosilicate glass systems, tamper-evident packaging, and packaging that reduces waste without compromising sterility or product protection.

Manufacturers and distributors should strengthen dual sourcing, regional warehousing, lot-level traceability, product serialization where relevant, and digital product content for procurement platforms. Commercial teams can improve conversion by pairing technical documentation, compliance certificates, sustainability data, application notes, and chemical compatibility guidance with transparent lead times and service-level commitments.

Research Methodology

This executive summary is based on triangulated secondary research, industry benchmarking, and structured market interpretation. Inputs include publicly available evidence from health agencies, research funding bodies, standards organizations, customs and trade references, scientific literature, procurement documentation, and regulatory frameworks affecting laboratory materials, sterility, packaging, and chemical safety.

The methodology prioritizes verified qualitative indicators over unsupported market estimates. Demand patterns are assessed across end-use sectors, material categories, regional investment signals, laboratory automation trends, quality requirements, sustainability expectations, and supply chain dynamics to produce decision-ready insights for manufacturers, distributors, investors, and procurement teams.

Conclusion

Laboratory glassware and plasticware remain foundational to scientific productivity, regulatory compliance, and industrial testing. The market is moving toward higher-quality, application-specific, traceable, automation-ready, and sustainable products as laboratories digitize workflows, automate sample handling, and manage rising testing complexity.

Suppliers that combine material science, quality assurance, regional supply resilience, sustainability credentials, and digital procurement readiness will be best positioned. Demand will continue to follow life sciences innovation, diagnostics expansion, public health priorities, environmental monitoring, food safety, and the global need for reliable laboratory infrastructure.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Laboratory Glassware & Plasticware Market, by Product Type

• 7.1. Beakers
  • 7.1.1. Low Form Beaker
  • 7.1.2. Tall Form Beaker
• 7.2. Flasks
  • 7.2.1. Erlenmeyer Flask
  • 7.2.2. Round Bottom Flask
  • 7.2.3. Volumetric Flask
• 7.3. Petri Dishes
  • 7.3.1. Multiwell Plate
  • 7.3.2. Standard Petri Dish
• 7.4. Pipettes
  • 7.4.1. Air Displacement Pipettes
  • 7.4.2. Micropipettes
  • 7.4.3. Volumetric Pipettes
• 7.5. Test Tubes
  • 7.5.1. Centrifuge Tube
  • 7.5.2. Standard Test Tube
• 7.6. Vials & Bottles

8. Laboratory Glassware & Plasticware Market, by Material

• 8.1. Glass
• 8.2. Plastic

9. Laboratory Glassware & Plasticware Market, by End User

• 9.1. Academic & Research Institutions
• 9.2. Clinical & Hospital Laboratories
• 9.3. Food & Beverage Manufacturers
• 9.4. Pharmaceutical & Biotechnology Companies

10. Laboratory Glassware & Plasticware Market, by Distribution Channel

• 10.1. Offline
• 10.2. Online

11. Laboratory Glassware & Plasticware Market, by Region

• 11.1. Asia-Pacific
• 11.2. North America
• 11.3. Latin America
• 11.4. Europe
• 11.5. Middle East
• 11.6. Africa

12. Laboratory Glassware & Plasticware Market, by Group

• 12.1. ASEAN
• 12.2. GCC
• 12.3. European Union
• 12.4. BRICS
• 12.5. G7
• 12.6. NATO

13. Laboratory Glassware & Plasticware Market, by Country

• 13.1. United States
• 13.2. Canada
• 13.3. Mexico
• 13.4. Brazil
• 13.5. United Kingdom
• 13.6. Germany
• 13.7. France
• 13.8. Russia
• 13.9. Italy
• 13.10. Spain
• 13.11. China
• 13.12. India
• 13.13. Japan
• 13.14. Australia
• 13.15. South Korea

14. Competitive Landscape

• 14.1. Market Concentration Analysis, 2025
  • 14.1.1. Concentration Ratio (CR)
  • 14.1.2. Herfindahl Hirschman Index (HHI)
• 14.2. Recent Developments & Impact Analysis, 2025
• 14.3. Product Portfolio Analysis, 2025
• 14.4. Benchmarking Analysis, 2025

15. Company Profiles

• 15.1. Advin Health Care Private Limited
• 15.2. Agilent Technologies, Inc.
• 15.3. Avantor, Inc.
• 15.4. Bellco Glass Inc.
• 15.5. Boeckel + Co (GmbH + Co) KG
• 15.6. Borosil Limited
• 15.7. Brand GMBH + CO KG
• 15.8. Chemglass, Inc.
• 15.9. Citotest Scientific Co.,Ltd.
• 15.10. Corning Incorporated
• 15.11. DWK Life Sciences GmbH
• 15.12. Eppendorf SE
• 15.13. Gerresheimer AG
• 15.14. Glassco Laboratory Equipments Pvt. Ltd.
• 15.15. GLASWARENFABRIK KARL HECHT GMBH & CO KG
• 15.16. Globe Scientific Inc.
• 15.17. Greiner Bio-One International GmbH
• 15.18. Hamilton Laboratory Glass Ltd.
• 15.19. Merck KGaA
• 15.20. Mettler-Toledo International Inc.
• 15.21. Poulten & Graf GmbH
• 15.22. Sarstedt AG & Co. KG
• 15.23. Sartorius AG
• 15.24. Savillex, LLC
• 15.25. Sibata Scientific Technology Holdings Limited
• 15.26. SP Wilmad-LabGlass
• 15.27. Supertek Glassware
• 15.28. Technosklo S.R.O.
• 15.29. Thermo Fisher Scientific Inc.
• 15.30. VITLAB GmbH